Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CK

Christopher F. Kraser — 4 Patents

ABArray Biopharma: 4 patents #146 of 335Top 45%
Bristol-Myers Squibb: 2 patents #1,827 of 3,969Top 50%
Boulder, CO: #1,557 of 5,018 inventorsTop 35%
Colorado: #10,815 of 40,980 inventorsTop 30%
Overall (All Time): #1,080,739 of 4,157,543Top 30%
4 Patents All Time
Christopher F. Kraser has been granted 4 US patents while listed as an inventor at Array Biopharma. The first was granted in 2015 and the most recent in June 2021. Christopher F. Kraser ranks #1,080,739 of 4,157,543 US inventors in our database (top 26.0%). Patent records list Christopher F. Kraser in Boulder, CO, US.

Patents per Year

Patents granted per year, 2015 to 2021Bar chart with a peak of 1 patents in 2015.peak 12015: 1 patents20152019: 1 patents20192020: 1 patents20202021: 1 patents2021

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11028093 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2021-06-08
10730880 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2020-08-04
10189845 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more 2019-01-29 $44,601,000
8962596 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases Laurence E. Burgess, Mark Laurence Boys, Robert D. Groneberg, Darren Harvey, Timothy Kercher +4 more 2015-02-24 $17,811,000